JOHN LOKEY: Open Payments
NPI 1124095542 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 21 payments from 10 companies in 2025. Trend: 2023 $314 · 2024 $404 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $146 |
| Lilly USA, LLC | 5 | $100 |
| Abbott Laboratories | 2 | $43 |
| Pulmonx Corporation | 1 | $41 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| ABBVIE INC. | 1 | $25 |
| Exact Sciences Corporation | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Boston Scientific Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Ozempic, MOUNJARO, FREESTYLE LIBRE, CHARTIS CATHETER, JARDIANCE, Wegovy, INSPIRE, LINZESS.
Industry payments across GA — which companies pay providers there.
